FDMT - 4D Molecular to layoff about 25% of workforce
2025-07-02 16:47:13 ET
More on 4D Molecular Therapeutics
- 4D Molecular Therapeutics gets FDA RMAT status for macular edema treatment
- Seeking Alpha’s Quant Rating on 4D Molecular Therapeutics
- Historical earnings data for 4D Molecular Therapeutics
- Financial information for 4D Molecular Therapeutics